December 06, 2020 Corporate and Business News

• San Diego Harley-Davidson Team Welcomes New Owner, Established Racecar Driver and Motorcycle Enthusiast Acquires Eighth Dealership

• Novartis analyses confirm benefit of Kymriah® with clinically meaningful rates of complete response seen in patients with certain advanced lymphomas

• Lancement de la première étude d'immunothérapie cellulaire UniCAR sur les tumeurs solides avancées

• Sysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia

• Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

• AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment VENCLEXTA®/VENCLYXTO® (venetoclax) in Chronic Lymphocytic Leukemia (CLL)

• Disease-Free Survival Data from CAPTIVATE Study Demonstrate Benefit of IMBRUVICA® (ibrutinib)-Based Regimen as Fixed Duration, First-Line Treatment for Patients with Chronic Lymphocytic Leukemia

• Back to Home

• Archive History